WHO ICTRP trial
Study on the anti-tumor effect of organic selenium-a clinical study of organic…
ChiCTR2100042874 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100042874 |
|---|---|
| Public title | Study on the anti-tumor effect of organic selenium-a clinical study of organic selenium combined with chemotherapy in the treatment of advanced pancreatic cancer |
| Scientific title | Study on the anti-tumor effect of organic selenium-a clinical study of organic selenium combined with chemotherapy in the treatment of advanced pancreatic cancer |
| Primary sponsor | Beijing Hospital of Traditional Chinese Medicine,Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Advanced pancreatic cancer |
| Interventions | control group:Placebo + chemotherapy;trial group:Organic selenium + chemotherapy |
| Registration date | Jan 30, 2021 |
| Target size | control group:67;trial group:67 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: